Family Medicine · Miami, FL
NPI
1154350577
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
3661 S. Miami Ave, Suite 806
Miami, FL, 33133
Phone (305) 856-2171
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
412 services
Medicare patients, 2024
65
Average age 67
Drug cost, 2024
$5.9M
7,491 prescriptions
Company payments, 2025
$528
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michelle R Powell was code 99214 (office e&m - established), 193 times for 57 patients. In total Michelle R Powell billed 412 services in 30 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 193 | 57 | $89.47 | $17K |
| 36415 Venipuncture Blood Collection | Office | 67 | 45 | $8.52 | $571 |
| 99213 Office E&M - Established | Office | 31 | 22 | $58.13 | $1,802 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 23 | 23 | $140.40 | $3,229 |
| 90480 Vaccine Administration | Office | 15 | 14 | $39.20 | $588 |
By year: 2022 $3,975 for 86 services; 2023 $19K for 283 services; 2024 $28K for 412 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 67 | 45 | $8.52 | $571 |
Medicare prescription drug claims, 2024
In 2024, the drug Michelle R Powell prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 477 prescriptions and refills. In total Michelle R Powell wrote 7,491 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 477 | 477 | 57 | $1.9M |
| Atorvastatin Calcium Generic | 357 | 447 | 48 | $1,353 |
| Rosuvastatin Calcium Generic | 321 | 433 | 49 | $1,471 |
| Amlodipine Besylate Generic | 265 | 327 | 34 | $612 |
| Descovy Emtricitabine/Tenofov Alafenam | 240 | 241 | 23 | $528K |
| Tivicay Dolutegravir Sodium | 232 | 232 | 24 | $610K |
| Dovato Dolutegravir Sodium/Lamivudine | 211 | 211 | 23 | $612K |
| Ezetimibe Generic | 174 | 252 | 29 | $1,214 |
| Pifeltro Doravirine | 160 | 160 | 21 | $274K |
| Omeprazole Generic | 128 | 148 | 18 | $1,112 |
| Metoprolol Succinate Generic | 120 | 144 | 13 | $867 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 110 | 110 | 12 | $396K |
| Testosterone Generic | 106 | 108 | 14 | $12K |
| Alprazolam Generic | 106 | 116 | 14 | $621 |
| Gabapentin Generic | 105 | 120 | 17 | $1,182 |
Brand drugs: 2,440 claims; generic drugs: 5,020 claims; opioid claims: 59.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michelle R Powell $528 ($528 in general payments such as food, travel and fees) from 2 companies. The largest payer was ViiV Healthcare Company with $325.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.